Company: RPTX
Filing Date: 2025-12-03
Form Type: PREM14A
Source: 0001193125-25-306948
Chunk: 268

Company: Repare Therapeutics Inc.
Filing Date: 2025-12-03
Form: PREM14A
Chunk 268
---
 to the Outside Date. |

| (g) | Except as provided under Section 6.2(f), nothing contained in this Section 6.2 shall limit in any way                                                 
 the obligation of the Company to convene and hold the Meeting in accordance with Section 2.5 of this Agreement while this Agreement remains in force. |

| (h) | Nothing in this Agreement shall prevent the Board of Directors or the Company from responding through a                                                                                                                                                   
 directors’ circular or otherwise as required by applicable Laws to an Acquisition Proposal where such response is not an acceptance, approval, endorsement or recommendation of such Acquisition Proposal and does not otherwise constitute a             
 Change of Recommendation; provided, that the Company shall provide the Purchaser and its outside legal counsel with a reasonable opportunity to review the form and content of such circular or other disclosure and shall make all reasonable amendments 
 to such circular or other disclosure as requested by the Purchaser and its outside legal counsel.                                                                                                                                                         |

| (i) | Notwithstanding the foregoing, nothing in Section 6.1 and this Section 6.2 shall require the sharing                                                                                                                                                     
 with the Purchaser of any information considered by external legal counsel of each of the Company and the Purchaser to be competitively sensitive information in connection with competition compliance principles, which competitively sensitive        
 information will be provided only to the external legal counsel or external expert of the Purchaser and shall not be shared by such legal counsel or expert with any other person unless it is first anonymized and aggregated such that it is no longer 
 considered by external legal counsel of each of the Company and the Purchaser to be competitively sensitive information in connection with competition compliance principles.                                                                            |

A-42

ARTICLE 7 CONDITIONS

| 7.1 | Mutual Conditions Precedent |

The Parties are not required to complete the Arrangement unless each of the following conditions is satisfied on or prior to the Effective Time, which conditions may only be waived, in whole or in part, by the mutual consent of each of the Parties:

| (a) | Arrangement Resolution. The Arrangement Resolution has been approved and adopted by the Shareholders at 
 the Meeting in accordance with the Interim Order.                                                       |

| (b) | Interim and Final Orders. The Interim Order and the Final Order have each been obtained on terms                                                                                         
 consistent with this Agreement, and have not been set aside or modified in a manner unacceptable to either the Company or the Purchaser, each acting reasonably, on appeal or otherwise. |

| (c